E
Lyell Immunopharma, Inc. LYEL
$0.5854 -$0.0209-3.45%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue 11.00K 34.00K 13.00K 3.00K 13.00K
Total Other Revenue -- -- -- -- --
Total Revenue 11.00K 34.00K 13.00K 3.00K 13.00K
Cost of Revenue -- -- -- -- --
Gross Profit 11.00K 34.00K 13.00K 3.00K 13.00K
SG&A Expenses 14.52M 11.77M 12.26M 13.49M 13.17M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -1.44M -730.00K -976.00K -1.09M -1.08M
Total Operating Expenses 61.75M 50.54M 51.54M 55.58M 59.08M
Operating Income -61.74M -50.51M -51.53M -55.58M -59.07M
Income Before Tax -191.94M -44.58M -45.81M -60.67M -52.93M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -191.94M -44.58M -45.81M -60.67M -52.93M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -191.94M -44.58M -45.81M -60.67M -52.93M
EBIT -61.74M -50.51M -51.53M -55.58M -59.07M
EBITDA -56.72M -45.83M -46.63M -50.55M -54.01M
EPS Basic -0.69 -0.17 -0.18 -0.24 -0.21
Normalized Basic EPS -0.13 -0.11 -0.11 -0.12 -0.13
EPS Diluted -0.69 -0.17 -0.18 -0.24 -0.21
Normalized Diluted EPS -0.13 -0.11 -0.11 -0.12 -0.13
Average Basic Shares Outstanding 279.95M 256.31M 255.40M 254.25M 252.80M
Average Diluted Shares Outstanding 279.95M 256.31M 255.40M 254.25M 252.80M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings